Indications of Effective Hyperbaric Oxygen Therapy... (2023 study) Skip to main content
Clinical Study Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2023

Indications of Effective Hyperbaric Oxygen Therapy Combined With Steroid Therapy for Sudden Hearing Loss.

Ohira S, Komori M, Tsuna Y, Nakamura M, Yamaguchi Y, Matsuura K, et al., Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2023

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers looked back at records of 109 patients with sudden hearing loss to compare those treated with hyperbaric oxygen therapy (HBOT) plus steroids against those treated with steroids only, and to see whether blood markers of inflammation were linked to recovery.

What They Found

In this retrospective study of 109 patients with sudden hearing loss, the group given HBOT plus steroids (59 sides) had a higher overall recovery rate than the steroid-only group (50 sides), particularly in severe cases. Blood markers of inflammation, the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), did not differ significantly by severity of hearing loss. In patients who also received HBOT, NLR and PLR were useful for predicting the effect. With cutoff values of 2.43 for NLR and 146.67 for PLR, lower values were linked to better recovery rates.

What This Means for Canadian Patients

For people with sudden hearing loss, this study found that those who received HBOT with steroids had higher recovery rates than those who received steroids alone, especially with severe hearing loss. The authors suggest that blood tests for NLR and PLR could be considered along with the severity of hearing loss when choosing treatment. Because patients were not randomly assigned, the study cannot show that HBOT caused the better recovery.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a retrospective comparison of 109 patients, not a randomized trial, so differences between the groups other than HBOT may have affected the recovery rates, and the abstract does not report the HBOT pressure or number of sessions.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 37853772
Year Published 2023
Journal Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
MeSH Terms Humans; Hearing Loss, Sudden; Hyperbaric Oxygenation; Hearing Loss, Sensorineural; Lymphocytes; Deafness; Steroids; Retrospective Studies

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology